These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis. Sun J; Cai S; Yan N; Mei H Eur J Med Chem; 2010 Mar; 45(3):1008-14. PubMed ID: 19969399 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of biologically active acycloAZT derivatives and related compounds. Murata M; Achiwa K Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):836-8. PubMed ID: 2347030 [TBL] [Abstract][Full Text] [Related]
26. [A comparative study of the neuraminidase activity of 2 strains of influenza A2 type virus]. Orlova NG; Mekhedov LN Vopr Virusol; 1970; 15(3):341-6. PubMed ID: 5472073 [No Abstract] [Full Text] [Related]
27. Hemolysis and fusion by influenza viruses with heat-inactivated neuraminidase activity. Hosaka Y; Seriburi O; Moran MG; Yasuda Y; Fukai K; Nerome K Biken J; 1982 Jun; 25(2):51-62. PubMed ID: 7138491 [TBL] [Abstract][Full Text] [Related]
28. An inhibition test for identifying the neuraminidase antigen on influenza viruses. Webster RG; Campbell CH Avian Dis; 1972; 16(5):1057-66. PubMed ID: 4344860 [No Abstract] [Full Text] [Related]
29. Structure-guided design of a novel class of benzyl-sulfonate inhibitors for influenza virus neuraminidase. Platis D; Smith BJ; Huyton T; Labrou NE Biochem J; 2006 Oct; 399(2):215-23. PubMed ID: 16776653 [TBL] [Abstract][Full Text] [Related]
30. Acyl amino acid derivatives as novel inhibitors of influenza neuraminidase. Kondoh M; Furutani T; Azuma M; Ooshima H; Kato J Biosci Biotechnol Biochem; 1997 May; 61(5):870-4. PubMed ID: 9178564 [TBL] [Abstract][Full Text] [Related]
31. Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design. Ghate AA; Air GM Eur J Biochem; 1998 Dec; 258(2):320-31. PubMed ID: 9874196 [TBL] [Abstract][Full Text] [Related]
32. Docking and 3D QSAR study of thiourea analogs as potent inhibitors of influenza virus neuraminidase. Sun J; Cai S; Mei H; Li J; Yan N; Wang Y J Mol Model; 2010 Dec; 16(12):1809-18. PubMed ID: 20213331 [TBL] [Abstract][Full Text] [Related]
33. Influenza virus neuraminidase and the viral surface. Kendal AP; Biddle F; Belyavin G Biochim Biophys Acta; 1968 Oct; 165(3):419-31. PubMed ID: 5754088 [No Abstract] [Full Text] [Related]
34. Molecular dynamics and free energy analysis of neuraminidase-ligand interactions. Bonnet P; Bryce RA Protein Sci; 2004 Apr; 13(4):946-57. PubMed ID: 15044728 [TBL] [Abstract][Full Text] [Related]
35. Neuraminidase action on the human urinary glycoprotein of Tamm and Horsfall. Pape L; Maxfield M Biochim Biophys Acta; 1967 Apr; 133(3):574-81. PubMed ID: 6068546 [No Abstract] [Full Text] [Related]
36. Neuraminidase activity of influenza virus-infected cells: localization and properties. Orlova TG; Orlova NG Acta Virol; 1975 Apr; 19(2):130-6. PubMed ID: 239558 [TBL] [Abstract][Full Text] [Related]
37. The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors. Hurt AC; Okomo-Adhiambo M; Gubareva LV Methods Mol Biol; 2012; 865():115-25. PubMed ID: 22528156 [TBL] [Abstract][Full Text] [Related]